PMC:7029448 / 15041-15417 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"201","span":{"begin":43,"end":52},"obj":"Species"}],"attributes":[{"id":"A201","pred":"tao:has_database_id","subj":"201","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In conclusion, while molecular testing for 2019-nCoV was quickly implemented in EU/EEA countries there is still room for improvement especially in the aspect of clinical validation of specificity and sensitivity, as could be expected considering the survey was taken in the very early phase of the laboratory response. Capability testing based on proficiency panels is needed."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T121","span":{"begin":31,"end":38},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T122","span":{"begin":330,"end":337},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"In conclusion, while molecular testing for 2019-nCoV was quickly implemented in EU/EEA countries there is still room for improvement especially in the aspect of clinical validation of specificity and sensitivity, as could be expected considering the survey was taken in the very early phase of the laboratory response. Capability testing based on proficiency panels is needed."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T108","span":{"begin":0,"end":318},"obj":"Sentence"},{"id":"T109","span":{"begin":319,"end":376},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In conclusion, while molecular testing for 2019-nCoV was quickly implemented in EU/EEA countries there is still room for improvement especially in the aspect of clinical validation of specificity and sensitivity, as could be expected considering the survey was taken in the very early phase of the laboratory response. Capability testing based on proficiency panels is needed."}